Clinical Trial Update: A Trial of Ipatasertib in Combination With Atezolizumab [Phase 1, Phase 2]

View source ↗

Summary

Update on a Phase 1/2 trial of ipatasertib in combination with atezolizumab for solid tumors, including glioblastoma multiforme and metastatic prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme
• Prostate Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• ipatasertib (ipatasertib)

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Solid Tumor, Glioblastoma Multiforme | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING